Comment on "Risk analysis of metformin use in prostate cancer: a national population-based study"

Aging Male. 2024 Dec;27(1):2340087. doi: 10.1080/13685538.2024.2340087. Epub 2024 Apr 8.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Humans
  • Male
  • Metformin* / therapeutic use
  • Prostatic Neoplasms* / epidemiology
  • Risk Assessment

Substances

  • Metformin